Western blotting revealed that apatinib significantly promotes mTOR phosphorylation in mouse tumor tissues, while FMD treatment leads to a significant inhibition of mTOR phosphorylation and HIF-1α expression (Fig. 4A). The gene discussed is MTOR; the disease is neoplasm.